Related Experiment Video
Updated: Oct 21, 2025

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
The circular RNA circCRIM1 inhibits osteosarcoma progression through sponging miR-513
Pengfei Wu1, Yinghui Kong2, Zhitang Dai1
1Department of Orthopaedics, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, No.1, Huanghe West Road, Huaiyin District, Huaian, 223300, Jiangsu, China.
Abstract:
Numerous studies have suggested that the abnormal expression of circular RNAs plays an essential role in the pathological progression of numerous tumors. Nonetheless, the functions and underlying mechanisms of the circular RNA circCRIM1 in osteosarcoma (OS) are still not fully understood. In this study, 47 classes of OS tissues and adjoining normal tissues were obtained from patients. Real-time PCR was employed to measure circCRIM1 expression levels in both OS tissues and cell lines. The proliferation, migration, and invasion ability in OS cell lines were measured by MTT assays, EDU assays, transwell migration experiments, and transwell invasion assays. The results demonstrated that the expression of circCRIM1 was notably decreased both in OS tissues and cell lines. Depressed circCRIM1 expression was correlated with lymph node metastasis, advanced FIGO stage, and low overall survival of OS patients. In addition, the results indicated that circCRIM1 could decrease the migration, invasion, and growth of OS cells. Further mechanistic studies indicated that circCRIM1 served as a competing endogenous RNA (ceRNA) of miR-513, leading to decreases in the proliferation, migration, and invasion of OS cells. Taken together, our data uncovered a significant role of the circCRIM1/miR-513 pathway in the proliferation, migration, and invasion of OS cell lines and suggested that circCRIM1 may serve as a possible therapeutic target for OS treatment.
Insights
Circular RNA CRIM1 (circCRIM1) is downregulated in osteosarcoma (OS), inhibiting tumor growth and metastasis. CircCRIM1 acts as a competing endogenous RNA (ceRNA) for miR-513, suggesting it as a potential therapeutic target for OS.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are implicated in tumor progression.
- The role of circCRIM1 in osteosarcoma (OS) remains unclear.
Purpose of the Study:
- To investigate the function and mechanism of circCRIM1 in osteosarcoma.
- To explore circCRIM1 as a potential therapeutic target for OS.
Main Methods:
- Quantification of circCRIM1 expression in OS tissues and cell lines using real-time PCR.
- Assessment of OS cell proliferation, migration, and invasion using MTT, EDU, transwell migration, and invasion assays.
- Mechanistic investigation of the circCRIM1/miR-513 axis.
Main Results:
- circCRIM1 expression was significantly decreased in OS tissues and cell lines.
- Lower circCRIM1 levels correlated with lymph node metastasis, advanced FIGO stage, and reduced overall survival.
- circCRIM1 overexpression suppressed OS cell proliferation, migration, and invasion.
- circCRIM1 functions as a ceRNA for miR-513, inhibiting OS progression.
Conclusions:
- The circCRIM1/miR-513 pathway plays a critical role in OS cell proliferation, migration, and invasion.
- circCRIM1 demonstrates potential as a therapeutic target for osteosarcoma treatment.
Related Concept Videos
Experimental RNAi
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

